NIH has awarded 89 grants that will provide funding to scientists proposing innovative research to address major challenges in biomedical science.
Researchers from Queen's University Belfast and the University of Leeds, as part of a pan-European partnership called the European Cancer Concord, have won the 2018 European Health Award.
Shirley MertzChristine BenjaminShirley Mertz was elected chair of the MBC Alliance and Christine Benjamin was elected vice chair beginning Nov. 1.
As the new president of the Association of American Cancer Institutes, Roy Jensen will focus on public policy at the state and local level as his presidential priority.
Craig Thompson, president and CEO of Memorial Sloan Kettering Cancer Center, resigned from two corporate boards of directors—the pharmaceutical company Merck & Co., and Charles River Laboratories International Inc., a company focused on early-stage drug development and manufacturing of novel compounds.
The year was 1998, location, Italian Alps. Jim and I were attending an intimate Pezcoller meeting organized by David Livingston. At that meeting, Jim presented something I had never seen in the entirety of my career—the eradication of cancer in mice following treatment with an antibody designed to inhibit a T cell checkpoint mechanism.
European Commission has approved Braftovi in combination with Mektovi for the treatment of adult patients with unresectable or metastatic melanoma with a BRAFV600 mutation, as detected by a validated test. This approval is applicable to all 28 European Union member states, as well as Liechtenstein, Iceland and Norway.
OBI Pharma, Inc., a Taiwan biopharma company, announced that FDA has granted Orphan Drug Designation for OBI-3424 for the treatment of acute lymphoblastic leukemia.
IMV Inc. announced that investigators are evaluating IMV's lead candidate, DPX-Survivac, in combination with low dose cyclophosphamide and Merck's checkpoint inhibitor Keytruda (pembrolizumab), in patients with persistent or recurrent/refractory diffuse large B-cell lymphoma.
Jean-Charles SoriaTony MokPasi JänneMargaret FotiThe European Society for Medical Oncology has announces four distinguished oncology professionals who will receive its annual awards during the ESMO 2018 Congress in Munich. The awardees are:
